Hannah V Woodcock
Hannah V Woodcock
1Centre for Inflammation and Tissue Repair, UCL Respiratory, Rayne Building, University College London, London, WC1E 6JF UK
1,#,
Jessica D Eley
Jessica D Eley
1Centre for Inflammation and Tissue Repair, UCL Respiratory, Rayne Building, University College London, London, WC1E 6JF UK
1,#,
Delphine Guillotin
Delphine Guillotin
1Centre for Inflammation and Tissue Repair, UCL Respiratory, Rayne Building, University College London, London, WC1E 6JF UK
1,
Manuela Platé
Manuela Platé
1Centre for Inflammation and Tissue Repair, UCL Respiratory, Rayne Building, University College London, London, WC1E 6JF UK
1,
Carmel B Nanthakumar
Carmel B Nanthakumar
2Fibrosis Discovery Performance Unit, Respiratory Therapy Area, Medicines Research Centre, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY UK
2,
Matteo Martufi
Matteo Martufi
3Target Sciences, Medicines Research Centre, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY UK
3,
Simon Peace
Simon Peace
2Fibrosis Discovery Performance Unit, Respiratory Therapy Area, Medicines Research Centre, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY UK
2,
Gerard Joberty
Gerard Joberty
4Cellzome, a GSK Company, Meyershofstrasse 1, 69117 Heidelberg, Germany
4,
Daniel Poeckel
Daniel Poeckel
4Cellzome, a GSK Company, Meyershofstrasse 1, 69117 Heidelberg, Germany
4,
Robert B Good
Robert B Good
2Fibrosis Discovery Performance Unit, Respiratory Therapy Area, Medicines Research Centre, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY UK
2,
Adam R Taylor
Adam R Taylor
2Fibrosis Discovery Performance Unit, Respiratory Therapy Area, Medicines Research Centre, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY UK
2,
Nico Zinn
Nico Zinn
4Cellzome, a GSK Company, Meyershofstrasse 1, 69117 Heidelberg, Germany
4,
Matthew Redding
Matthew Redding
1Centre for Inflammation and Tissue Repair, UCL Respiratory, Rayne Building, University College London, London, WC1E 6JF UK
1,
Ellen J Forty
Ellen J Forty
1Centre for Inflammation and Tissue Repair, UCL Respiratory, Rayne Building, University College London, London, WC1E 6JF UK
1,
Robert E Hynds
Robert E Hynds
5CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, WC1E 6DD UK
6Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, NW1 1AT UK
5,6,
Charles Swanton
Charles Swanton
5CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, WC1E 6DD UK
6Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, NW1 1AT UK
5,6,
Morten Karsdal
Morten Karsdal
7Nordic Bioscience, Herlev, 2730 Denmark
7,
Toby M Maher
Toby M Maher
8Fibrosis Research Group, Inflammation, Repair & Development Section, NHLI, Imperial College, London, SW3 6LY UK
8,
Andrew Fisher
Andrew Fisher
9Newcastle Fibrosis Research Group, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK
9,
Giovanna Bergamini
Giovanna Bergamini
4Cellzome, a GSK Company, Meyershofstrasse 1, 69117 Heidelberg, Germany
4,
Richard P Marshall
Richard P Marshall
2Fibrosis Discovery Performance Unit, Respiratory Therapy Area, Medicines Research Centre, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY UK
2,
Andy D Blanchard
Andy D Blanchard
2Fibrosis Discovery Performance Unit, Respiratory Therapy Area, Medicines Research Centre, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY UK
2,
Paul F Mercer
Paul F Mercer
1Centre for Inflammation and Tissue Repair, UCL Respiratory, Rayne Building, University College London, London, WC1E 6JF UK
1,
Rachel C Chambers
Rachel C Chambers
1Centre for Inflammation and Tissue Repair, UCL Respiratory, Rayne Building, University College London, London, WC1E 6JF UK
1,✉
1Centre for Inflammation and Tissue Repair, UCL Respiratory, Rayne Building, University College London, London, WC1E 6JF UK
2Fibrosis Discovery Performance Unit, Respiratory Therapy Area, Medicines Research Centre, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY UK
3Target Sciences, Medicines Research Centre, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY UK
4Cellzome, a GSK Company, Meyershofstrasse 1, 69117 Heidelberg, Germany
5CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, WC1E 6DD UK
6Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, NW1 1AT UK
7Nordic Bioscience, Herlev, 2730 Denmark
8Fibrosis Research Group, Inflammation, Repair & Development Section, NHLI, Imperial College, London, SW3 6LY UK
9Newcastle Fibrosis Research Group, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK
Subject terms: Transforming growth factor beta, TOR signalling, Respiratory tract diseases
© The Author(s) 2020
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.